Stock Research for GSK

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

GSK Stock Chart & Research Data

The GSK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GSK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


GSK Due diligence Resources & Stock Charts

The GSK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View GSK Detailed Price Forecast - CNN Money CNN View GSK Detailed Summary - Google Finance
Yahoo View GSK Detailed Summary - Yahoo! Finance Zacks View GSK Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View GSK Trends & Analysis - Trade-Ideas Barrons View GSK Major Holders - Barrons
NASDAQ View GSK Call Transcripts - NASDAQ Seeking View GSK Breaking News & Analysis - Seeking Alpha
Spotlight View GSK Annual Report - CompanySpotlight.com OTC Report View GSK OTC Short Report - OTCShortReport.com
TradeKing View GSK Fundamentals - TradeKing Charts View GSK SEC Filings - Bar Chart
WSJ View Historical Prices for GSK - The WSJ Morningstar View Performance/Total Return for GSK - Morningstar
MarketWatch View the Analyst Estimates for GSK - MarketWatch CNBC View the Earnings History for GSK - CNBC
StockMarketWatch View the GSK Earnings - StockMarketWatch MacroAxis View GSK Buy or Sell Recommendations - MacroAxis
Bullish View the GSK Bullish Patterns - American Bulls Short Pains View GSK Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View GSK Stock Mentions - StockTwits PennyStocks View GSK Stock Mentions - PennyStockTweets
Twitter View GSK Stock Mentions - Twitter Invest Hub View GSK Investment Forum News - Investor Hub
Yahoo View GSK Stock Mentions - Yahoo! Message Board Seeking Alpha View GSK Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for GSK - SECform4.com Insider Cow View Insider Transactions for GSK - Insider Cow
CNBC View GSK Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for GSK - OTC Markets
Yahoo View Insider Transactions for GSK - Yahoo! Finance NASDAQ View Institutional Holdings for GSK - NASDAQ


Stock Charts

FinViz View GSK Stock Insight & Charts - FinViz.com StockCharts View GSK Investment Charts - StockCharts.com
BarChart View GSK Stock Overview & Charts - BarChart Trading View View GSK User Generated Charts - Trading View




Latest Financial News for GSK


Targeting 'bubble baby' disease, this gene therapy company is planting a flag in the East Bay
Posted on Thursday December 13, 2018

Orchard Therapeutics is tackling "bubble baby" disease and other rare genetic conditions with gene therapy.


What’s the Market Opportunity for Zejula?
Posted on Thursday December 13, 2018

How Is Tesaro Positioned in December? As per GlaxoSmithKline’s (GSK) analyst call transcript, Tesaro’s (TSRO) Zejula is competing with AstraZeneca’s (AZN) Lynparza and Clovis Oncology’s (CLVS) Rubraca as maintenance therapy in the second-line platinum-sensitive ovarian cancer indication. GlaxoSmithKline (GSK) has estimated the annual incidence of these patients in the US market to be around 5,000.


Big Pharma Grants License to Kill Drug Programs as Costs Surge
Posted on Wednesday December 12, 2018

Industry executives long trained to sniff out blockbuster drugs are now having to hone another skill: a feel for medicines that are unsafe, unoriginal or just unlikely to succeed. As costs escalate, knowing when to terminate those medicines has become just as important as when to move forward. At AstraZeneca Plc, research boss Mene Pangalos figures he shut down about half the projects in the pipeline after joining eight years ago.


3 Dividend Stocks That Pay You More Than Exxon Does
Posted on Wednesday December 12, 2018

Looking for big yield? ExxonMobil has it, but these three stocks should also be on your radar.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.